251 related articles for article (PubMed ID: 36239063)
1. Adenosine receptors as emerging therapeutic targets for diabetic kidney disease.
Pak ES; Cha JJ; Cha DR; Kanasaki K; Ha H
Kidney Res Clin Pract; 2022 Sep; 41(Suppl 2):S74-S88. PubMed ID: 36239063
[TBL] [Abstract][Full Text] [Related]
2. Orally active, species-independent novel A
Dorotea D; Cho A; Lee G; Kwon G; Lee J; Sahu PK; Jeong LS; Cha DR; Ha H
Exp Mol Med; 2018 Apr; 50(4):1-14. PubMed ID: 29674631
[TBL] [Abstract][Full Text] [Related]
3. Adenosine Receptors as Novel Targets for the Treatment of Various Cancers.
Gorain B; Choudhury H; Yee GS; Bhattamisra SK
Curr Pharm Des; 2019; 25(26):2828-2841. PubMed ID: 31333092
[TBL] [Abstract][Full Text] [Related]
4. Adenosine receptor subtypes: characterization and therapeutic regulation.
Olah ME; Stiles GL
Annu Rev Pharmacol Toxicol; 1995; 35():581-606. PubMed ID: 7598508
[TBL] [Abstract][Full Text] [Related]
5. Targeting Adenosine Receptors: A Potential Pharmacological Avenue for Acute and Chronic Pain.
Vincenzi F; Pasquini S; Borea PA; Varani K
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33218074
[TBL] [Abstract][Full Text] [Related]
6. Medicinal chemistry of adenosine, P2Y and P2X receptors.
Jacobson KA; Müller CE
Neuropharmacology; 2016 May; 104():31-49. PubMed ID: 26686393
[TBL] [Abstract][Full Text] [Related]
7. Adenosine Receptors as Potential Therapeutic Analgesic Targets.
Haddad M; Cherchi F; Alsalem M; Al-Saraireh YM; Madae'en S
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685963
[TBL] [Abstract][Full Text] [Related]
8. The role of receptor structure in determining adenosine receptor activity.
Olah ME; Stiles GL
Pharmacol Ther; 2000 Feb; 85(2):55-75. PubMed ID: 10722120
[TBL] [Abstract][Full Text] [Related]
9. Canine mast cell adenosine receptors: cloning and expression of the A3 receptor and evidence that degranulation is mediated by the A2B receptor.
Auchampach JA; Jin X; Wan TC; Caughey GH; Linden J
Mol Pharmacol; 1997 Nov; 52(5):846-60. PubMed ID: 9351976
[TBL] [Abstract][Full Text] [Related]
10. Machine Learning for Discovery of New ADORA Modulators.
Puhl AC; Gao ZG; Jacobson KA; Ekins S
Front Pharmacol; 2022; 13():920643. PubMed ID: 35814244
[TBL] [Abstract][Full Text] [Related]
11. Dual Actions of A
Pak ES; Jeong LS; Hou X; Tripathi SK; Lee J; Ha H
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073488
[TBL] [Abstract][Full Text] [Related]
12. Focusing on Adenosine Receptors as a Potential Targeted Therapy in Human Diseases.
Effendi WI; Nagano T; Kobayashi K; Nishimura Y
Cells; 2020 Mar; 9(3):. PubMed ID: 32213945
[TBL] [Abstract][Full Text] [Related]
13. Emerging adenosine receptor agonists.
Gao ZG; Jacobson KA
Expert Opin Emerg Drugs; 2007 Sep; 12(3):479-92. PubMed ID: 17874974
[TBL] [Abstract][Full Text] [Related]
14. In Silico Drug Design for Purinergic GPCRs: Overview on Molecular Dynamics Applied to Adenosine and P2Y Receptors.
Salmaso V; Jacobson KA
Biomolecules; 2020 May; 10(6):. PubMed ID: 32466404
[TBL] [Abstract][Full Text] [Related]
15. Identification of V6.51L as a selectivity hotspot in stereoselective A
Wang X; Jespers W; Prieto-Díaz R; Majellaro M; IJzerman AP; van Westen GJP; Sotelo E; Heitman LH; Gutiérrez-de-Terán H
Sci Rep; 2021 Jul; 11(1):14171. PubMed ID: 34238993
[TBL] [Abstract][Full Text] [Related]
16. Curcumin Stereoisomer, Cis-Trans Curcumin, as a Novel Ligand to A
Hamilton LJ; Pattabiraman M; Zhong HA; Walker M; Vaughn H; Chandra S
Pharmaceuticals (Basel); 2023 Jun; 16(7):. PubMed ID: 37513829
[TBL] [Abstract][Full Text] [Related]
17. Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development.
Jacobson KA; Tosh DK; Jain S; Gao ZG
Front Cell Neurosci; 2019; 13():124. PubMed ID: 30983976
[TBL] [Abstract][Full Text] [Related]
18. Role of Adenosine Receptor(s) in the Control of Vascular Tone in the Mouse Pudendal Artery.
Labazi H; Tilley SL; Ledent C; Mustafa SJ
J Pharmacol Exp Ther; 2016 Mar; 356(3):673-80. PubMed ID: 26718241
[TBL] [Abstract][Full Text] [Related]
19. Molecular Simulations and Drug Discovery of Adenosine Receptors.
Wang J; Bhattarai A; Do HN; Akhter S; Miao Y
Molecules; 2022 Mar; 27(7):. PubMed ID: 35408454
[TBL] [Abstract][Full Text] [Related]
20. Medicinal Chemistry and Therapeutic Potential of Agonists, Antagonists and Allosteric Modulators of A1 Adenosine Receptor: Current Status and Perspectives.
Deb PK; Deka S; Borah P; Abed SN; Klotz KN
Curr Pharm Des; 2019; 25(25):2697-2715. PubMed ID: 31333094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
